New Diagnostic Test is 1,000 Times More Sensitive than Conventional Tests
Researchers developed ultrabright fluorescent nanolabels called plasmonic-fluors to overcome limitations in point-of-care diagnostic tests.
Read MorePosted by Andy Lundin | Feb 10, 2023 | Diagnostic Technologies |
Researchers developed ultrabright fluorescent nanolabels called plasmonic-fluors to overcome limitations in point-of-care diagnostic tests.
Read MorePosted by Andy Lundin | Feb 8, 2023 | Flu & Respiratory Infections |
BD received Emergency Use Authorization from the US FDA for a new molecular diagnostic combination test for respiratory viruses.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Diagnostic Technologies, Disease States |
A new saliva-based test that can predict the risk of developing different kinds of cancers and other serious diseases is now available.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Covid 19 |
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read More